Logo image
Back
One-year follow-up evaluation of 260 premature infants with respiratory distress syndrome and birth weights of 700 to 1350 grams randomized to two rescue doses of synthetic surfactant or air placebo
Journal article   Peer reviewed

One-year follow-up evaluation of 260 premature infants with respiratory distress syndrome and birth weights of 700 to 1350 grams randomized to two rescue doses of synthetic surfactant or air placebo

Alice Gong, Endla Anday, Stephen Boros, Richard Bucciarelli, David Burchfield, Janet Zucker, Walker Long and Reprint requests: Alice Gong, MD, Division of Neonatology, Department of Pediatrics, University of Texas Health Sciences Center at San Antonio, 7705 Floyd Curl Dr., San Antonio, TX 78284- 7812.
The Journal of pediatrics, v 126(5), pp S68-S74
01 May 1995
DOI: https://doi.org/10.1016/S0022-3476(95)70010-2
Featured in Collection :   UN Sustainable Development Goals @ Drexel

Abstract

RDS ROP CLD IVH A-aPo2
A multicenter, randomized, double-blind, placebo-controlled trial of synthetic surfactant therapy for premature infants with respiratory distress syndrome (RDS) and birth weights of 700 to 1350 gm demonstrated a reduction in severity of RDS, morbidity, and neonatal and 1-year mortality. Of the 419 infants who were entered in the study, 80% of the surviving infants in both the air placebo group (122) and the synthetic surfactant group (138) returned for the follow-up evaluation at 1-year adjusted age. The only significant difference observed at follow-up was a reduction in the incidence of mild cerebral palsy in the synthetic surfactant group (air placebo group, 8 of 122 [7%]; synthetic surfactant group, 3 of 138 [2%]; relative risk 0.306; 95% confidence interval 0.094, 0.999). No differences were observed between the air placebo and synthetic surfactant treatment groups with respect to health status of the infants, including the incidence of retinopathy of prematurity and neurodevelopmental delays. The difference in the overall incidence of impairment among the 1-year survivors in the air placebo group (43 of 122 [35%]) and in the synthetic surfactant group (40 of 138 [29%]) was not statistically significant. The results of this 1-year follow-up study show that rescue treatment with synthetic surfactant in infants weighing 700 to 1300 gm is not associated with adverse developmental consequences despite the improvement in survival. (J P EDIATR 1995;126:S68-74.)

Metrics

9 Record Views
16 citations in Web of Science
22 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
Web of Science research areas
Pediatrics
Logo image